RankAlpha logo
Back to Rankings

AGIO

AgiosF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

AI scenario view

RankAlpha Sentiment AI
B+
Bull case
20%
Probability
Target price
$5.19
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
Most likely
B
Base case
50%
Probability
Target price
$4.08
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
B-
Bear case
30%
Probability
Target price
$2.60
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2025-10-10
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
0.0
Score

AI commentary

Market sentiment is cautious and event-driven: low absolute price levels keep institutional interest limited and amplify moves on clinical, BD, or financing news [#RankAlpha][#EDGAR]. Short-term tone hinges on cash/runway updates and upcoming results.

RankAlpha Sentiment AI - 2025-10-10
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

-eventQuarterly earnings / guidance updateHigh impact

Quarterly results and management commentary that can change cash-runway expectations and near-term guidance; historically a volatility driver [#EDGAR][#RankAlpha].

-catalystClinical readouts (hematology / rare disease)High impact

Mid-/late-stage efficacy or safety data for core programs — binary outcomes that materially re-rate valuation if positive or negative [#EDGAR].

-catalystBusiness development / partneringHigh impact

Licensing or co-development deals that extend runway or de-risk assets; timing and scale uncertain [#PR].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2025-10-10 • Updated nightlySource: Internal modelMethodology